Stock Detail
ELI LILLY AND COMPANY
Drug Manufacturers Major
LLY @ Yahoo Finance | LLY Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $36.83 | $37.48 | $0.00 | 0.00% | 1.96 | $37.65 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $37.46 | $36.80 | 6.12M | 41.83B | 8.82M | 8.80 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 37.72 | 37.28 | 37.04 | 36.60 | 36.36 |
Stock Profile
Eli Lilly and Company engages in the discovery, development, manufacture, and sale of primarily pharmaceutical products in the United States and internationally. The company's products include neuroscience products, which include Zyprexa, Prozac, Strattera, Cymbalta, Permax, Symbyax, and Yentreve; endocrinology products that consist primarily of Humalog, Humulin, Actos, Evista, Forteo, and Humatrope; and oncology products, which comprise primarily of Gemzar and Alimta. It also offers cardiovascular products that consist primarily of ReoPro and Xigris; and anti-infectives, which primarily include Ceclor and Vancocin. The other pharmaceutical product group includes Cialis, Axid, and other miscellaneous pharmaceutical products and services. In addition, Eli Lilly offers animal health products that include Tylan, Rumensin, Coban, and other products for livestock and poultry. It primarily sells its pharmaceutical products through wholesalers that serve pharmacies, physicians and other health care professionals, and hospitals. Eli Lilly has a collaboration agreement with HistoRx, Inc. to apply the HistoRx AQUA platform for quantitative pathology analysis; and with Alkermes, Inc. to develop and commercialize inhaled formulations of parathyroid hormone for the treatment of osteoporosis. The company was founded by Eli Lilly in 1876 and is based in Indianapolis, Indiana.